OHI shorts build 20% in a month, stock climbs anyway

Omega Healthcare Investors has accumulated a notably larger short position over the past month, even as the stock has pushed higher into Thursday's earnings release.

Short interest in OHI climbed 20.5% over the past 30 days to roughly 15.8 million shares, now equal to 5.3% of the free float. The build was not gradual: the bulk of it arrived in a single step around October 9, when short shares jumped by more than 1.2 million in one session, and the position has held steady since. Days to cover based on the official FINRA settlement figure stand at 7.6, one of the higher readings across healthcare REITs. Despite all of that, the stock rose 4.7% over the past week to $47.01, outpacing a median gain of roughly 3.6% for its closest peers including SBRA, VTR and NHI. Borrow costs remain low at 0.44%, and availability is extremely loose at 2,796%, meaning there is far more capacity to borrow than there is existing short interest. The borrow market is not signalling any stress, even as the short count itself has grown.

The analyst community is pulling in different directions. Citizens upgraded OHI to Market Outperform on October 22, a move that cut against the broader tide. Wells Fargo trimmed its target from $48 to $46 last week, while UBS and Barclays each lowered their targets earlier in October, though both kept their existing ratings. The consensus mean target of $51.37 implies around 9% upside from current levels, and the consensus sits at hold with three outperform ratings against nine holds. Bulls point to improving operator coverage ratios at skilled nursing facilities and management's active capital deployment, with a constructive view suggesting a price path toward $56 on deal-driven accretion. Bears flag the unpredictable SNF reimbursement environment, labour cost pressure, reliance on third-party operators and specific tenant risk around the PACS Group, with the CommuniCare portfolio sale seen as a near-term earnings headwind. EPS momentum over 30 and 90 days ranks in the 95th and 87th percentiles respectively, and the company's track record on estimate beats ranks in the 94th percentile, both factors that complicate the bear case on near-term figures.

Options positioning leans cautious but not extreme. The put/call ratio of 1.36 is slightly above its 20-day average of 1.32, a z-score of just 0.36, well within normal bounds and far from the 52-week high of 1.80. The options market is not pricing aggressive downside protection. Historical price reactions offer some context without pointing to an outcome: across the four most recent quarterly prints, OHI fell between 1.4% and 2.8% on the day of results and between 3.8% and 5.7% over the following five sessions.

The print will test whether a month of rising short interest was prescient positioning against specific operator or reimbursement risks, or premature given the run of estimate beats and the stock's outperformance of peers through the reporting window.